Table 4.

Factors associated with in-hospital survival among COVID-19 cancer patients with respiratory failure (n = 65)

	Univariable analysis			Multivariable analysis
Variables	Odds ratio	95% CI	P value	Odds ratio	95% CI	P value
Male	2.769	0.958–8.009	0.060	1.050	0.090–12.266	0.969
DNR	2.667	0.876–8.122	0.084	11.605	0.478–281.509	0.132
Smoker	5.420	1.392–21.107	0.015	5.804	1.847–39.746	0.043
Lactic dehydrogenase, U/L	1.004	1.001–1.007	0.008	1.004	1.001–1.012	0.025
Lactate, mg/dL	1.022	0.999–1.045	0.064	1.032	0.969–1.100	0.321
D-dimer, ug/mL	1.254	1.022–1.540	0.030	1.189	0.826–1.526	0.174
SOFA score	1.110	0.991–1.243	0.070	0.792	0.513–1.222	0.292
MAP score	1.415	1.028–1.948	0.033	0.330	0.037–2.936	0.320
Vasopressor use	3.870	1.276–11.735	0.017	5.437	1.202–24.593	0.028
New renal replacement therapy during admission	6.968	0.825–58.844	0.075	3.523	1.203–61.108	0.034
CMV infection	0.889	0.780–1.014	0.080	1.264	0.840–1.901	0.260

CI confidence interval, DNR do not resuscitate, SOFA sequential organ failure assessment, MAP mean arterial pressure, CMV cytomegalovirus